You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III adult diffuse large cell lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Frontline of ASCT in High-risk DLBCL

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Apr 26, 2023

    Chidamide in Recurrent and Refractory Diffuse Large b

    Enrolling by invitation
    • Diffuse Large B-cell Lymphoma
    • Suzhou, Jiangsu, China
      Second Affiliated Hospital of Soochow University
    Jan 9, 2023

    Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Diffuse Large B Cell Lymphoma
    • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
    • Tianjin, Tianjin, China
      Tianjin Cancer Hospital
    Nov 19, 2023

    DLBCL, High-grade B-cell Lymphoma Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • High-grade B-cell Lymphoma
    • Loncastuximab Tesirine
    • (no location specified)
    Dec 13, 2022

    Advanced DLBCL, Extra-nodal Involvement, Large Mass, Radiotherapy Trial (6-8 cycles (21 days per cycle) of Standard R-CHOP

    Not yet recruiting
    • Advanced Diffuse Large B-Cell Lymphoma
    • +2 more
    • 6-8 cycles (21 days per cycle) of Standard R-CHOP chemotherapy
    • Radiotherapy beyond standard R-CHOP Chemotherapy
    • (no location specified)
    May 24, 2023

    Relapsed/Refractory Diffuse Large B Cell Lymphoma Trial in Seoul (Glofitamab, Poseltinib, Lenalidomide)

    Recruiting
    • Relapsed/Refractory Diffuse Large B Cell Lymphoma
    • Glofitamab, Poseltinib, Lenalidomide
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 28, 2022

    Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Itacitinib
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 6, 2023

    Diffuse Large B-cell Lymphoma Trial in Tampa, Philadelphia (Tisagenlecleucel, Ibrutinib)

    Terminated
    • Diffuse Large B-cell Lymphoma
    • Tampa, Florida
    • +1 more
    Jan 27, 2023

    Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

    Completed
    • Diffuse Large Cell Diffuse Lymphoma
    • Follicular Lymphoma
    • Questionnaires
    • Collection of clinical data and treatments
    • Dijon, France
      Chu Dijon Bourogne
    Jan 31, 2023

    AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

    Completed
    Has Results
    • AIDS-related Diffuse Large Cell Lymphoma
    • +8 more
    • Eldoret, Kenya
    • +1 more
    Sep 12, 2022

    Lymphoma, Large B-Cell, Diffuse Trial (Cyclophosphamide, TLI, Fludarabine)

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • (no location specified)
    Aug 18, 2023

    Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma:

    Completed
    • Diffuse Large B-cell Lymphoma
      • East Hanover, New Jersey
        Novartis
      Jun 16, 2023

      Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

      Not yet recruiting
      • Follicular Lymphoma
      • +3 more
      • Tazemetostat Pill
      • New York, New York
        Weill Cornell Medicine/NewYork-Presbyterian Hospital
      Jun 28, 2023

      Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)

      Not yet recruiting
      • Lymphoma
      • Lymphoma, Large B-Cell, Diffuse
      • Boston, Massachusetts
      • +1 more
      Apr 4, 2023

      Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma (DLBCL)
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Sep 18, 2023

      Diffuse Large B Cell Lymphoma,DLBCL Trial in Chengdu (PM 8.4 mg/m2, PM 11.2 mg/m2)

      Recruiting
      • Diffuse Large B Cell Lymphoma，DLBCL
      • PM 8.4 mg/m2
      • PM 11.2 mg/m2
      • Chengdu, Sichuan, China
        West China Hospital Sichuan University
      Jan 15, 2023

      Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • Low-Dose Decitabine plus anti-PD-1
      • Beijing, Beijing, China
        ChinaPLAGH
      Apr 18, 2023

      DLBCL - Diffuse Large B Cell Lymphoma Trial in Toronto (Cyclophosphamide, TLI)

      Recruiting
      • DLBCL - Diffuse Large B Cell Lymphoma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jul 19, 2023

      Diffuse Large B Cell Lymphoma Trial (Pembrolizumab, Rituximab, Ifosfamide)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Headington, Oxford, United Kingdom
      • +1 more
      Nov 2, 2022

      Diffuse Large B Cell Lymphoma, Relapsed DLBCL, Refractory DLBCL Trial in Boston (Copanlisib, Venetoclax)

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • +2 more
      • Duarte, California
      • +2 more
      Nov 10, 2022

      Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • (no location specified)
      Jan 20, 2023

      Recurrent DLBCL, Recurrent Grade 3b Follicular Lymphoma, Recurrent High Grade B-Cell Lymphoma Trial in Duarte (Biopsy,

      Not yet recruiting
      • Recurrent Diffuse Large B-Cell Lymphoma
      • +11 more
      • Biopsy
      • +5 more
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      Communication Training Intervention for Large B-Cell Lymphoma

      Recruiting
      • Lymphoma, B-Cell
      • +5 more
      • Hematolo-GIST Training
      • Participants Appointment
      • New York, New York
      • +2 more
      Jul 3, 2023

      Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL

      Recruiting
      • Diffuse Large B Cell Lymphoma
        • Salvador, Bahia, Brazil
        • +9 more
        Jul 24, 2023

        Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma

        Completed
        • Lymphoma, Large B-cell, Diffuse
          • Jeonju, Korea, Republic of
            Chonbuk National University Hospital
          Feb 2, 2023